Cargando…
IL-10 promoter hypomethylation is associated with increased IL-10 expression and poor survival in hepatocellular carcinoma
BACKGROUND: Epigenetic alterations of tumor-associated genes contribute to the pathogenesis of virtually all cancer types. We evaluated the methylation status of the interleukin-10 (IL-10) gene promoter and assessed its association with IL-10 mRNA expression and clinical prognosis in hepatocellular...
Autores principales: | Zhang, Xianjing, Lu, Mingzhu, Xu, Yun, He, Guangzhao, Liu, Qian, Zhu, Jing, Zhang, Changsong, Zhang, Xiaoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797925/ https://www.ncbi.nlm.nih.gov/pubmed/35116889 http://dx.doi.org/10.21037/tcr.2019.07.33 |
Ejemplares similares
-
IL10 hypomethylation is associated with the risk of gastric cancer
por: Tang, Junjian, et al.
Publicado: (2021) -
Hypomethylation of IL10 and IL13 Promoters in CD4(+) T Cells of Patients with Systemic Lupus Erythematosus
por: Zhao, Ming, et al.
Publicado: (2010) -
The Silencing of RECK Gene is Associated with Promoter Hypermethylation and Poor Survival in Hepatocellular Carcinoma
por: Zhang, Changsong, et al.
Publicado: (2012) -
IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Yang, Jie-Ru, et al.
Publicado: (2022) -
Increased serum IL-17 and decreased serum IL-10 and IL-35 levels correlate with the progression of COPD
por: Jiang, Shenghua, et al.
Publicado: (2018)